News
Videos
Conferences
Events
Resources
Subscribe

Dr. Matthew Matasar

Dr. Matthew Matasar is chief of the Division of Blood Disorders at Rutgers Cancer Institute and RWJBarnabas Health in New Brunswick, New Jersey.

Articles by Dr. Matthew Matasar

$Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.$

Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T

ByDr. Matthew Matasar

April 22nd 2025

Latest Updated Articles

Trending on CURE

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

Breaking Down the Prostate Cancer Treatment Renaissance

Epkinly Plus Chemo Elicits Durable Responses in DLBCL

Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma

Insights Into What’s New in Blood Cancer Care

© 2025 MJH Life Sciences^®

All rights reserved.